Key result
Patients with HFpEF had significantly higher plasma levels of myeloperoxidase compared to healthy controls (34.7 vs 22.6 ng/mL, p=0.026), reflecting increased leukocyte activation and oxidative stress.
Why the study?
Inflammation and oxidative stress are thought to contribute to HFpEF through endothelial dysfunction, with myeloperoxidase linking both processes, but its clinical and vascular associations in HFpEF required definition.
Observational (n=73)
No
Absolute Event Rate: 34.7% vs 22.6%
p-value: p=0.026
Plasma myeloperoxidase levels are elevated in HFpEF patients compared to controls and are associated with male sex, diabetes, and diastolic dysfunction, highlighting a potential role for oxidative stress and inflammation in the disease pathophysiology.
MPO elevation in HFpEF may identify candidates for targeted therapy; leaves open efficacy pending randomized trials.
Background: Inflammation and oxidative stress are thought to play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF) through the development of endothelial dysfunction. Myeloperoxidase (MPO) functions as a link between oxidative stress and inflammation and is an interesting therapeutic target. The objective of this observational cohort study was to compare MPO levels between HFpEF and old controls, to define clinical characteristics associated with high levels of MPO and to assess the relation between MPO levels and vascular function. Methods: Patients with HFpEF (N = 55) and controls >60 years (N = 18) were prospectively included. All subjects underwent complete echocardiography and blood sampling. MPO levels were dosed by ELISA assay. Effective arterial elastance (Ea) and peripheral arterial tonometry (EndoPAT reactive hyperemia index RHI and augmentation index AIx) were used to assess vascular function. Characteristics between groups defined by the median of MPO were compared using independent samples t-test or chi square test. Results: Patients with HFpEF (80 ± 8.7 years, 65% female) had higher levels of MPO compared to controls (75 ± 5.0 years, 72% female) (34.7 ng/mL [22.7; 44.0] vs 22.6 [18.2; 32.0], p = 0.026). MPO levels were correlated with markers of inflammation; C-reactive protein (Pearson’s R = 0.46, p = 0.001) and neutrophile to lymphocyte ratio (R = 0.36, p = 0.031) and with signs of left ventricular (LV) remodelling and elevated filling pressures, namely NT-proBNP levels (R = 0.32, p = 0.019), decreased LV ejection fraction (LVEF, R = –0.36, p = 0.008) and E/e’ ratio (R = 0.35, p = 0.011). HFpEF patients with levels of MPO above the median were more often men (48% vs 21%, p = 0.037) and suffered more often from diabetes (48% vs 18%, p = 0.017). Intriguingly, they had lower indices of vascular stiffness (augmentation index 11.1 [0.1; 30.7] vs 19.9 [10.5; 33.4], p = 0.018 and arterial elastance Ea 2.06 ± 0.676 vs 2.43 ± 0.721, p = 0.065) and there was no difference in endothelial function (1.82 [1.34; 2.30] vs 1.66 [1.32; 1.95], p = 0.55). Conclusions: HFpEF patients have higher levels of MPO than controls, reflecting leukocyte activation and oxidative stress. Among patients, high levels of MPO are associated with male sex, diabetic status, subtle left ventricular dysfunction and pronounced diastolic dysfunction. The association between oxidative stress and vascular stiffness, on the other hand could not be demonstrated. Clinical Trial Registration: Clinical trial NCT03197350.
No takes yet. Share an insight, caveat, or question.
Lejeune et al. (2023) conducted an observational in Heart failure with preserved ejection fraction (HFpEF) (n=73). Heart failure with preserved ejection fraction (HFpEF) vs. Healthy controls >60 years was evaluated on Plasma myeloperoxidase (MPO) levels (ng/mL) (p=0.026). Patients with HFpEF had significantly higher plasma levels of myeloperoxidase compared to healthy controls (34.7 vs 22.6 ng/mL, p=0.026), reflecting increased leukocyte activation and oxidative stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: